Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients

by Brosens, R. P. M., Belt, E. J. T. H., Haan, J. C., Buffart, T. E., Carvalho, B., Grabsch, H., Quirke, P., Cuesta, M. A., Engel, A. F., Ylstra, B., Meijer, G. A.
Published 2011

FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study

by Su, X, Zhan, P, Gavine, P R, Morgan, S, Womack, C, Ni, X, Shen, D, Bang, Y-J, Im, S-A, Ho Kim, W, Jung, E-J, Grabsch, H I, Kilgour, E
Published 2014

Deletion of Chromosome 4q Predicts Outcome in Stage II Colon Cancer Patients

by Brosens, R. P. M., Belt, E. J. T. H., Haan, J. C., Buffart, T. E., Carvalho, B., Grabsch, H., Quirke, P., Cuesta, M. A., Engel, A. F., Ylstra, B., Meijer, G. A.
Published 2010

KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study

by van Grieken, N C T, Aoyma, T, Chambers, P A, Bottomley, D, Ward, L C, Inam, I, Buffart, T E, Das, K, Lim, T, Pang, B, Zhang, S L, Tan, I B, Carvalho, B, Heideman, D A M, Miyagi, Y, Kameda, Y, Arai, T, Meijer, G A, Tsuburaya, A, Tan, P, Yoshikawa, T, Grabsch, H I
Published 2013

KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study

by van Grieken, N C T, Aoyama, T, Chambers, P A, Bottomley, D, Ward, L C, Inam, I, Buffart, T E, Das, K, Lim, T, Pang, B, Zhang, S L, Tan, I B, Carvalho, B, Heideman, D A M, Miyagi, Y, Kameda, Y, Arai, T, Meijer, G A, Tsuburaya, A, Tan, P, Yoshikawa, T, Grabsch, H I
Published 2014

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas

by Bain, G H, Collie-Duguid, E, Murray, G I, Gilbert, F J, Denison, A, Mckiddie, F, Ahearn, T, Fleming, I, Leeds, J, Phull, P, Park, K, Nanthakumaran, S, Grabsch, H I, Tan, P, Welch, A, Schweiger, L, Dahle-Smith, A, Urquhart, G, Finegan, M, Petty, R D
Published 2014

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas

by Bain, G H, Collie-Duguid, E, Murray, G I, Gilbert, F J, Denison, A, Mckiddie, F, Ahearn, T, Fleming, I, Leeds, J, Phull, P, Park, K, Nanthakumaran, S, Matula, K M, Grabsch, H I, Tan, P, Welch, A, Schweiger, L, Dahle-Smith, A, Urquhart, G, Finegan, M, Petty, R D
Published 2016

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)

by Feilchenfeldt, J, Varga, Z, Siano, M, Grabsch, H I, Held, U, Schuknecht, B, Trip, A, Hamaguchi, T, Gut, P, Balague, O, Khanfir, K, Diebold, J, Jochum, W, Shoji, H, Kushima, R, Wagner, D, Shimada, Y, Cats, A, Knuth, A, Moch, H, Aebi, S, Hofer, S
Published 2015

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)

by Feilchenfeldt, J, Varga, Z, Siano, M, Grabsch, H I, Held, U, Schuknecht, B, Trip, A, Hamaguchi, T, Gut, P, Balague, O, Khanfir, K, Diebold, J, Jochum, W, Shoji, H, Kushima, R, Wagner, D, Shimada, Y, Cats, A, Knuth, A, Moch, H, Aebi, S, Hofer, S
Published 2015

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas

by Bain, G H, Collie-Duguid, E, Murray, G I, Gilbert, F J, Denison, A, Mckiddie, F, Ahearn, T, Fleming, I, Leeds, J, Phull, P, Park, K, Nanthakumaran, S, Grabsch, H I, Tan, P, Welch, A, Schweiger, L, Dahle-Smith, A, Urquhart, G, Finegan, M, Matula, K M, Petty, R D
Published 2015